Form 4 for GILD Gilead Sciences

Accepted 2026-06-02 18:04:05 ET · period of report 2026-06-01 · accession 0001638643-26-000022 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MT	2026-06-02 18:04	2026-06-01	GILD	O'Day Daniel Patrick	COB, CEO, Dir	S - Sale	$131.46	-15.0K	617.6K	-2%	-$1.97M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-06-01	S	D	10,900	$131.10	621,667	D	—	—	(F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. (F2) Sale prices for the transactions reported range from $130.66 to $131.64. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
2	Common	Common Stock	2026-06-01	S	D	3,062	$132.22	618,605	D	—	—	(F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. (F3) Sale prices for the transactions reported range from $131.71 to $132.70. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
3	Common	Common Stock	2026-06-01	S	D	1,038	$132.97	617,567	D	—	—	(F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. (F4) Sale prices for the transactions reported range from $132.71 to $133.295. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.